The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next-generation sequencing (NGS) market is ...

FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...

Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...

Detailed price information for Creative Medical Technology Holdings Inc (CELZ-Q) from The Globe and Mail including charting and trades.

In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...

On Nov 8, Japanese drugmaker Takeda Pharmaceutical Co Ltd launched a partnership with OrigiMed to promote the R&D and ...

This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as its history from the comparative analysis of the first amino acid sequences ...

OGT, using their specialised expertise in the development of superior hybridisation-based capture technology, ensures that ...

Presentations at AMP 2025 show utility of Delve Detect for diagnosing complex CNS infections, such as co-infection and culture-negative presentations ...

TORONTO, Nov. 10, 2025 /CNW/ - Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion Detection Kit has received marketing authoriza ...